GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 129 filers reported holding GW PHARMACEUTICALS PLC in Q2 2016. The put-call ratio across all filers is 0.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $225,000 | -32.4% | 2,311 | -21.7% | 0.01% | -7.7% |
Q1 2018 | $333,000 | -12.6% | 2,953 | -6.2% | 0.01% | -7.1% |
Q1 2017 | $381,000 | +37.5% | 3,148 | +4.1% | 0.01% | +27.3% |
Q2 2016 | $277,000 | -13.7% | 3,025 | -14.1% | 0.01% | 0.0% |
Q1 2015 | $321,000 | +9.2% | 3,521 | -18.8% | 0.01% | +10.0% |
Q4 2014 | $294,000 | – | 4,338 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lamond Capital Partners LLC | 134,230 | $9,085,000 | 5.95% |
VHCP Management, LLC | 311,853 | $21,106,000 | 5.81% |
Iguana Healthcare Management, LLC | 60,000 | $4,061,000 | 1.96% |
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 366,187 | $24,784,000 | 0.95% |
ACUTA CAPITAL PARTNERS, LLC | 20,000 | $1,354,000 | 0.92% |
United Asset Strategies, Inc. | 14,278 | $966,000 | 0.41% |
PRUDENTIAL PLC | 823,408 | $55,728,000 | 0.24% |
Rock Springs Capital Management LP | 28,000 | $1,895,000 | 0.22% |
CLOUGH CAPITAL PARTNERS L P | 84,600 | $5,726,000 | 0.20% |
Eventide Asset Management | 25,000 | $1,692,000 | 0.18% |